Application of radioactive iodine-125 microparticles in hepatocellular carcinoma with portal vein embolus

Table 4 Comparison of portal vein diameter, liver function indicators, alpha-fetoprotein level, and platelet level between the two groups of patients before and after treatment

Time	Cases	AFP in ng/mL	ALT in U/L	AST in U/L	TBIL in μmol/L	PLT as 109/L	Portal vein trunk diameter in mm	WBC as 109/L
Preoperative
Joint group	52	557.9 ± 196.4	57.2 ± 25.8	66.8 ± 29.0	20.9 ± 5.8	162.6 ± 47.2	13.90 ± 2.51	5.16 ± 1.80
Control group	44	570.2 ± 211.6	54.0 ± 19.8	61.2 ± 25.7	22.5 ± 7.5	167.0 ± 51.6	14.10 ± 2.66	5.30 ± 1.95
t value		0.288	0.651	0.964	1.154	0.426	0.369	0.357
P value		0.774	0.515	0.338	0.251	0.671	0.713	0.722
8 wk after surgery
Joint group	52	138.2 ± 69.5	114.2 ± 47.0	123.0 ± 51.0	35.0 ± 9.4	113.0 ± 55.2	11.20 ± 2.14	3.72 ± 1.15
Control group	44	196.4 ± 73.2	82.6 ± 29.3	89.6 ± 33.7	27.1 ± 8.7	139.0 ± 50.1	12.64 ± 2.00	3.90 ± 1.24
t value		3.890	3.720	3.582	4.126	2.330	3.290	0.719
P value		< 0.001	< 0.001	< 0.001	< 0.001	0.022	0.001	0.473

AFP: Alpha-fetoprotein; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; PLT: Platelet; TBIL: Total bilirubin; WBC: White blood cells.